These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 9830438)

  • 1. A 2-week pretreatment with 13-cis-retinoic acid + interferon-alpha-2a prior to definitive radiation improves tumor tissue oxygenation in cervical cancers.
    Dunst J; Hänsgen G; Krause U; Füchsel G; Köhler U; Becker A
    Strahlenther Onkol; 1998 Nov; 174(11):571-4. PubMed ID: 9830438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxygenation of cervical cancers during radiotherapy and radiotherapy + cis-retinoic acid/interferon.
    Dunst J; Hänsgen G; Lautenschläger C; Füchsel G; Becker A
    Int J Radiat Oncol Biol Phys; 1999 Jan; 43(2):367-73. PubMed ID: 10030263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 13-cis-retinoic acid plus interferon alpha-2a: highly active systemic therapy for squamous cell carcinoma of the cervix.
    Lippman SM; Kavanagh JJ; Paredes-Espinoza M; Delgadillo-Madrueño F; Paredes-Casillas P; Hong WK; Holdener E; Krakoff IH
    J Natl Cancer Inst; 1992 Feb; 84(4):241-5. PubMed ID: 1734085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A phase II study of 13-cis retinoic acid plus interferon alpha-2a in advanced stage penile carcinoma: an Eastern Cooperative Oncology Group study (E3893).
    Skeel RT; Huang J; Manola J; Wilding G; Dreicer R; Walker P; Muggia F; Crawford ED; Dutcher JP; Loehrer PJ
    Cancer Invest; 2003; 21(1):41-6. PubMed ID: 12643008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intratumoral pO2-measurements as predictive assay in the treatment of carcinoma of the uterine cervix.
    Knocke TH; Weitmann HD; Feldmann HJ; Selzer E; Pötter R
    Radiother Oncol; 1999 Nov; 53(2):99-104. PubMed ID: 10665785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized phase II/III trial of interferon Alfa-2a with and without 13-cis-retinoic acid in patients with progressive metastatic renal cell Carcinoma: the European Organisation for Research and Treatment of Cancer Genito-Urinary Tract Cancer Group (EORTC 30951).
    Aass N; De Mulder PH; Mickisch GH; Mulders P; van Oosterom AT; van Poppel H; Fossa SD; de Prijck L; Sylvester RJ
    J Clin Oncol; 2005 Jun; 23(18):4172-8. PubMed ID: 15961764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 13-cis-retinoic acid and interferon alpha-2a: effective combination therapy for advanced squamous cell carcinoma of the skin.
    Lippman SM; Parkinson DR; Itri LM; Weber RS; Schantz SP; Ota DM; Schusterman MA; Krakoff IH; Gutterman JU; Hong WK
    J Natl Cancer Inst; 1992 Feb; 84(4):235-41. PubMed ID: 1734084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro radiosensitization of human cervical carcinoma cells by combined use of 13-cis-retinoic acid and interferon-alpha2a.
    Ryu S; Kim OB; Kim SH; He SQ; Kim JH
    Int J Radiat Oncol Biol Phys; 1998 Jul; 41(4):869-73. PubMed ID: 9652851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase II clinical trial of 13-cis-retinoic acid and interferon-alpha-2a in patients with advanced esophageal carcinoma.
    Enzinger PC; Ilson DH; Saltz LB; Martin LK; Kelsen DP
    Cancer; 1999 Mar; 85(6):1213-7. PubMed ID: 10189124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interferon alfa-2a and 13-cis-retinoic acid in renal cell carcinoma: antitumor activity in a phase II trial and interactions in vitro.
    Motzer RJ; Schwartz L; Law TM; Murphy BA; Hoffman AD; Albino AP; Vlamis V; Nanus DM
    J Clin Oncol; 1995 Aug; 13(8):1950-7. PubMed ID: 7636535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined interferon-alfa, 13-cis-retinoic acid, and alpha-tocopherol in locally advanced head and neck squamous cell carcinoma: novel bioadjuvant phase II trial.
    Shin DM; Khuri FR; Murphy B; Garden AS; Clayman G; Francisco M; Liu D; Glisson BS; Ginsberg L; Papadimitrakopoulou V; Myers J; Morrison W; Gillenwater A; Ang KK; Lippman SM; Goepfert H; Hong WK
    J Clin Oncol; 2001 Jun; 19(12):3010-7. PubMed ID: 11408495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Feasibility study: concurrent 13-cis-retinoic acid, alfa-2a interferon and radiotherapy in the treatment of 23 patients with advanced cervix uteri epidermoid carcinoma].
    Paredes Espinoza M; Delgadillo Madrueño F; Paredes Casillas P; Delgadillo Hernández JJ; Ayala Castellanos MM; Alvarez Márquez V; Buenrostro Ahued MA; Arias Castro G
    Ginecol Obstet Mex; 1995 May; 63():205-9. PubMed ID: 7789851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor hypoxia, p53, and prognosis in cervical cancers.
    Haensgen G; Krause U; Becker A; Stadler P; Lautenschlaeger C; Wohlrab W; Rath FW; Molls M; Dunst J
    Int J Radiat Oncol Biol Phys; 2001 Jul; 50(4):865-72. PubMed ID: 11429213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxygen tension in transplanted mouse osteosarcomas during fractionated high-LET- and low-LET radiotherapy--predictive aspects for choosing beam quality?
    Auberger T; Thürriegl B; Freude T; Weissfloch L; Senekowitsch-Schmidke R; Kneschaurek P; Wagner FM; Molls M
    Strahlenther Onkol; 1999 Jun; 175 Suppl 2():52-6. PubMed ID: 10394398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase II study of 13-cis-retinoic acid plus interferon-alpha 2a in heavily pretreated squamous carcinoma of the cervix.
    Hallum AV; Alberts DS; Lippman SM; Inclan L; Shamdas GJ; Childers JM; Surwit EA; Modiano M; Hatch KD
    Gynecol Oncol; 1995 Mar; 56(3):382-6. PubMed ID: 7705672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypoxia-induced treatment failure in advanced squamous cell carcinoma of the uterine cervix is primarily due to hypoxia-induced radiation resistance rather than hypoxia-induced metastasis.
    Rofstad EK; Sundfør K; Lyng H; Tropé CG
    Br J Cancer; 2000 Aug; 83(3):354-9. PubMed ID: 10917551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of 32 cervico-uterine cancer patients with 13-cis-retinoic acid and interferon alpha].
    Paredes Espinoza M; Lippman SM; Kavanagh JJ; Delgadillo Madrueño F; Paredes Casillas P; Bañuelos Acosta O; Alvarez Márquez V; Buenrostro Ahued MA; de Alba Ayala I; Arias Castro G
    Rev Invest Clin; 1994; 46(2):105-11. PubMed ID: 8052740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxygenation status of cervical carcinomas before and during spinal anesthesia for application of brachytherapy.
    Weitmann HD; Gustorff B; Vaupel P; Knocke TH; Pötter R
    Strahlenther Onkol; 2003 Sep; 179(9):633-40. PubMed ID: 14628130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interferon-alpha2a and 13-cis-retinoic acid with radiation treatment for high-grade glioma.
    Dillman RO; Shea WM; Tai DF; Mahdavi K; Barth NM; Kharkar BR; Poor MM; Church CK; DePriest C
    Neuro Oncol; 2001 Jan; 3(1):35-41. PubMed ID: 11305415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interferon-alpha 2a, 13-cis-retinoic acid and radiotherapy for locally advanced carcinoma of the cervix: a pilot study.
    Park TK; Lee JP; Kim SN; Choi SM; Kudelka AP; Kavanagh JJ
    Eur J Gynaecol Oncol; 1998; 19(1):35-8. PubMed ID: 9476056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.